USANA Health Sciences, Inc. (NYSE: USNA) (the “Company”) today announced financial results for its fiscal fourth quarter and fiscal year ended December 28, 2024.
The Company completed the acquisition of a 78.8% controlling ownership stake of Hiya Health Products, LLC (“Hiya”) on December 23, 2024. Consequently, the Company’s fourth quarter and fiscal year 2024 include the effect of less than a week of Hiya’s operating results, which were not significant to the Company’s consolidated results for the same periods.
In light of the Hiya acquisition, the Company is now including metrics for Adjusted diluted EPS(1) and Adjusted EBITDA(2). Net earnings, Diluted EPS, Adjusted diluted EPS(1) and Adjusted EBITDA(2) in this press release represent amounts attributable to USANA.
Key Financial Results and Guidance
Fourth Quarter 2024 vs. Fourth Quarter 2023
Net sales of $214 million versus $221 million.
Net earnings of $4.5 million as compared to $16.8 million.
Diluted EPS of $0.23 as compared with $0.87.
Adjusted diluted EPS(1) of $0.64 as compared with $0.87.
Adjusted EBITDA(2) of $25 million versus $32 million.
USANA Active Customers of 454,000 versus 483,000.
Fiscal Year 2024 vs. Fiscal Year 2023
Net sales of $855 million as compared with $921 million.
Net earnings of $42.0 million as compared to $63.8 million.
Diluted EPS of $2.19 versus $3.30.
Adjusted diluted EPS(1) of $2.59 as